Cincinnati Children's Hospital Medical Center
3333 Burnet Avenue
179 articles with Cincinnati Children's Hospital Medical Center
Record number makes Valentine's Day a little sweeter for patients and families
Scientists at Cincinnati Children's Hospital Medical Center have created and tested a decision tool that appears to be the most accurate, non-invasive method yet developed to predict asthma in young children.
December 7 Research Roundup: Genes for Dementia, Genes for Obesity, Genes for Tissue Regeneration...
12/7/2018There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Roivant Sciences teamed with Cincinnati Children’s Hospital Medical Center to launch Aruvant Sciences. Roivant is the umbrella company run by Vivek Ramaswamy, which has launched a number of companies with “vant” in the names.
Roivant Launches Aruvant Sciences and Roivant Foundation in Partnership with Cincinnati Children’s Hospital Medical Center
Aruvant’s pipeline anchored by RVT-1801, an investigational gene therapy for sickle cell disease and β-thalassemia
Harvard Medical School and Brigham and Women’s Hospital are leading the call to remove the papers from the lab of Dr. Piero Anversa, a pioneer in the field of cardiac research.
BridgeBio Pharma LLC Signs Joint Collaboration Agreement with Cincinnati Children's to Accelerate Development of Genetic Disease Therapeutics
BridgeBio Pharma LLC and Cincinnati Children's Hospital Medical Center today announced they are entering into a research collaboration to identify and develop genetic disease therapies.
Pediatric hematology nurse becomes a better caretaker after breast cancer battle
Big News for Little Patients as Cincinnati Children’s Hospital Advances its Pediatric Testing with the Atellica Solution
Cincinnati Children’s Hospital Medical Center, one of the most distinguished pediatric hospitals in the U.S., is the first children’s hospital to adopt the Atellica® Solution.
September 28 Research Roundup: Growing an Esophagus, Bacteria and Parkinson’s, and a Soft Caterpi...
9/28/2018There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Database Links Body's Genetic Rhythms to Drug Metabolism in Human Tissues
Cincinnati Children's Jumps to Number Two Spot in Nation In U.S. News Best Children's Hospitals Rankings
For the first time ever, Cincinnati Children's Hospital Medical Center ranks second in the nation among all Honor Roll hospitals in U.S.News and World Report's 2018-2019 Best Children's Hospitals ranking.
Study Suggests Modulating CHD8 Might Help Some People with Complex Condition
Cincinnati Children's Hospital Successfully Tests New Method of Monitoring Pediatric Cancer Patient Body Temperature
TempTraq® Wearable, Bluetooth Patch Measures Temperature Continuously, Detecting Fevers Faster and More Consistently than Episodic Body Temperature Monitoring
Scientists at Cincinnati Children's Hospital Medical Center have uncovered three distinct subtypes of eosinophilic esophagitis (EoE), an emerging food allergic disease.
By studying a rare liver disease called Alagille syndrome, scientists from Cincinnati Children's and the University of California San Francisco (UCSF) have discovered the mechanism behind an unusual form of tissue regeneration that may someday reduce the need for expensive and difficult-to-obtain organ transplants.
Researchers trying to help people suffering from paralysis after a spinal cord injury or stroke mapped critical brain-to-spinal cord nerve connections that drive voluntary movement in forelimbs, a development that scientists say allows them to start looking for specific repair strategies.
Plenty of exciting news in the research world. Here’s a look at some of the top stories.
Severe traumatic brain injury in children was associated with increased risk for later onset of attention-deficit/hyperactivity (ADHD) up to about seven years after injury, according to a study in JAMA Pediatrics.
Cincinnati Children's Hospital Medical Center Release: Study Suggests Way to Attack Deadly, Untreatable Nerve Tumors
Genomic profiling of mostly untreatable and deadly nerve sheath tumors led scientists to test a possible therapeutic strategy that inhibited tumor growth in lab tests on human tumor cells and mouse models, according to research in the journal Cancer Cell.